The overlooked subgroup: preterm neonates with elevated serum creatinine outside neonatal AKI criteria.

IF 3.1 3区 医学 Q1 PEDIATRICS
Chih-Chia Chen, Yung-Chieh Lin, Chao-Ching Huang
{"title":"The overlooked subgroup: preterm neonates with elevated serum creatinine outside neonatal AKI criteria.","authors":"Chih-Chia Chen, Yung-Chieh Lin, Chao-Ching Huang","doi":"10.1038/s41390-025-04365-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To characterize risks and outcomes of preterm neonates with elevated serum creatinine (SCr) not meeting acute kidney injury (AKI) criteria.</p><p><strong>Methods: </strong>This cohort study included neonates <31 weeks' gestation admitted to a university hospital. Elevated SCr was defined as exceeding the 95th percentile for postnatal age without meeting standard AKI criteria in neonates <28 or 28-30 weeks. Perinatal/neonatal risks and discharge outcomes were compared among elevated SCr, SCr-AKI, and no SCr-AKI subgroups.</p><p><strong>Results: </strong>Among 810 infants, 156 had SCr-AKI, 623 had no SCr-AKI, and 31 had elevated SCr. Compared to no SCr-AKI, the elevated SCr subgroup had lower birthweight, higher rates of small-for-gestational-age, respiratory distress, hemodynamic instability, prolonged invasive ventilation, lower anthropometric z-scores, and higher mortality, despite similar gestational age. Compared to SCr-AKI, they had higher gestational age and higher rates of small-for-gestational-age, with similar mortality. Adjusted models showed elevated SCr (adjusted relative risk [aRR], 3.74) and SCr-AKI (aRR, 3.95) predicted higher mortality versus no SCr-AKI.</p><p><strong>Conclusion: </strong>Gestational age-specific SCr references are critical for identifying preterm neonates with elevated SCr levels outside AKI criteria, who face neonatal risks and distinct mortality outcomes.</p><p><strong>Impact statement: </strong>The risks and outcomes of preterm neonates with elevated serum creatinine (SCr) levels that do not meet Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury (AKI) criteria require further investigation. These neonates have distinct exposure profiles compared to those with KDIGO SCr-AKI and a poorer prognosis than those without SCr-AKI. They also have higher mortality than neonates without SCr-AKI. Our findings highlight the importance of gestational age-specific SCr reference values in neonatal care to better identify at-risk preterm infants beyond KDIGO criteria, enabling early intervention and improved outcomes.</p>","PeriodicalId":19829,"journal":{"name":"Pediatric Research","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41390-025-04365-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To characterize risks and outcomes of preterm neonates with elevated serum creatinine (SCr) not meeting acute kidney injury (AKI) criteria.

Methods: This cohort study included neonates <31 weeks' gestation admitted to a university hospital. Elevated SCr was defined as exceeding the 95th percentile for postnatal age without meeting standard AKI criteria in neonates <28 or 28-30 weeks. Perinatal/neonatal risks and discharge outcomes were compared among elevated SCr, SCr-AKI, and no SCr-AKI subgroups.

Results: Among 810 infants, 156 had SCr-AKI, 623 had no SCr-AKI, and 31 had elevated SCr. Compared to no SCr-AKI, the elevated SCr subgroup had lower birthweight, higher rates of small-for-gestational-age, respiratory distress, hemodynamic instability, prolonged invasive ventilation, lower anthropometric z-scores, and higher mortality, despite similar gestational age. Compared to SCr-AKI, they had higher gestational age and higher rates of small-for-gestational-age, with similar mortality. Adjusted models showed elevated SCr (adjusted relative risk [aRR], 3.74) and SCr-AKI (aRR, 3.95) predicted higher mortality versus no SCr-AKI.

Conclusion: Gestational age-specific SCr references are critical for identifying preterm neonates with elevated SCr levels outside AKI criteria, who face neonatal risks and distinct mortality outcomes.

Impact statement: The risks and outcomes of preterm neonates with elevated serum creatinine (SCr) levels that do not meet Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury (AKI) criteria require further investigation. These neonates have distinct exposure profiles compared to those with KDIGO SCr-AKI and a poorer prognosis than those without SCr-AKI. They also have higher mortality than neonates without SCr-AKI. Our findings highlight the importance of gestational age-specific SCr reference values in neonatal care to better identify at-risk preterm infants beyond KDIGO criteria, enabling early intervention and improved outcomes.

被忽视的亚组:未达到新生儿AKI标准的血清肌酐升高的早产儿。
背景:探讨血清肌酐(SCr)升高不符合急性肾损伤(AKI)标准的早产儿的风险和结局。结果:在810名婴儿中,156名患有SCr- aki, 623名无SCr- aki, 31名SCr升高。与无SCr- aki相比,SCr升高亚组的出生体重较低,小胎龄发生率较高,呼吸窘迫,血流动力学不稳定,有创通气时间延长,人体测量z评分较低,尽管胎龄相似,但死亡率较高。与SCr-AKI相比,他们有更高的胎龄和更高的小胎龄发生率,死亡率相似。校正后的模型显示,SCr(校正相对危险度[aRR], 3.74)和SCr- aki (aRR, 3.95)升高预示着比无SCr- aki更高的死亡率。结论:妊娠年龄特异性SCr参考对于识别未达到AKI标准的SCr水平升高的早产儿至关重要,这些早产儿面临新生儿风险和不同的死亡率结果。影响声明:血清肌酐(SCr)水平升高且不符合肾脏疾病:改善全球结局(KDIGO)急性肾损伤(AKI)标准的早产儿的风险和结局需要进一步调查。与患有KDIGO SCr-AKI的新生儿相比,这些新生儿具有不同的暴露概况,并且比没有SCr-AKI的新生儿预后更差。他们的死亡率也高于没有SCr-AKI的新生儿。我们的研究结果强调了妊娠年龄特异性SCr参考值在新生儿护理中的重要性,可以更好地识别超出KDIGO标准的高危早产儿,从而实现早期干预和改善结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Research
Pediatric Research 医学-小儿科
CiteScore
6.80
自引率
5.60%
发文量
473
审稿时长
3-8 weeks
期刊介绍: Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of children''s diseases and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信